DUBLIN--(BUSINESS WIRE)--The 'Virtual Clinical Trials Market - Focused Insights 2024-2029' report has been added to ResearchAndMarkets.com's offering.

都柏林--（商业新闻短讯）--“以市场为中心的2024-2029年虚拟临床试验”报告已添加到ResearchAndMarkets.com的产品中。

The Virtual Clinical Trials Market was valued at USD 2.64 billion in 2023, and is expected to reach USD 7.11 billion by 2029, rising at a CAGR of 17.95%.

2023年，虚拟临床试验市场价值26.4亿美元，预计到2029年将达到71.1亿美元，复合年增长率为17.95%。

North America dominates the global virtual clinical trials market due to the high advancement in clinical trials, digitalization, and IoT adoption in health facilities and clinical trials, the increasing surge of telemedicine and telehealth, and the wide acceptance of technologies in healthcare management.

由于临床试验、数字化和物联网技术在卫生设施和临床试验中的高度进步，远程医疗和远程保健的激增，以及医疗保健管理技术的广泛接受，北美在全球虚拟临床试验市场上占据主导地位。

The U.S. and Canada are the two major countries performing clinical trials. Due to stringent regulations and high costs, most vendors seek better options to handle the market scenario. The North American virtual clinical trials market witnessed exponential growth amid the COVID-19 crisis. Traditional clinical trials witnessed various challenges during the pandemic, thereby increasing the adoption of VCT in the market..

美国和加拿大是进行临床试验的两个主要国家。由于严格的法规和高昂的成本，大多数供应商寻求更好的选择来应对市场情况。在新型冠状病毒肺炎危机期间，北美虚拟临床试验市场呈指数增长。传统的临床试验在大流行期间遇到了各种挑战，从而增加了VCT在市场上的采用。。

MARKET TRENDS & DRIVERS

市场趋势和驱动因素

Breaking Down Barriers in Women's Health Clinical Studies

打破妇女健康临床研究的障碍

Globally, the rising women's health issues led to an increased burden of healthcare settings. Clinical studies are constantly evolving and growing rapidly to increase access to women's health issues. However, women tend to be harder to recruit for clinical studies due to socioeconomic factors, but the emergence of virtual clinical studies design helps ease restraints to participation.

在全球范围内，不断上升的女性健康问题导致医疗保健环境的负担增加。临床研究不断发展并迅速增长，以增加对妇女健康问题的了解。然而，由于社会经济因素，女性往往更难招募临床研究，但虚拟临床研究设计的出现有助于缓解参与的限制。

Patient recruitment is one of the challenging factors in running clinical studies. However, certain socioeconomic elements, such as the disproportionate burden of childcare, make recruiting women harder and more challenging for clinical trials. In women's health clinical studies, this factor is only exacerbated.

患者招募是进行临床研究的挑战性因素之一。然而，某些社会经济因素，例如不成比例的育儿负担，使得招募女性更加困难，临床试验也更具挑战性。在女性健康临床研究中，这一因素只会加剧。

According to the Clinical Trials Arena Report 2023, between 2010 and 2015, the proportion of women's health clinical studies in developed countries that included decentralized factors varied between 1.5% and 3% each year. However, with increasing attention to women's health, decentralization has become more popular in women's health clinical studies in recent years..

根据《2023年临床试验竞技场报告》，2010年至2015年间，发达国家女性健康临床研究的比例（包括分散因素）每年在1.5%至3%之间变化。然而，随着人们对女性健康的日益关注，近年来，权力下放在女性健康临床研究中越来越受欢迎。。

Rising Integration of More Advanced Systems and Tools

提高更先进系统和工具的集成度

Virtual clinical trials leverage tools, technology, and systems to collect data from patient participants remotely from their working or living places. Virtual clinical trials have already started using eConsent, electronic patient-reported outcomes (ePRO), and telemedicine. In addition, the increased focus on integrating wearable devices and sensors for data collection in recent years helps continuously monitor several health parameters in real-time.

虚拟临床试验利用工具、技术和系统从患者参与者的工作或生活场所远程收集数据。虚拟临床试验已经开始使用eConsent，电子患者报告结果（ePRO）和远程医疗。此外，近年来，人们越来越关注集成可穿戴设备和传感器进行数据收集，这有助于实时连续监测多个健康参数。

In addition, 'Bring-Your-Own-Devices' is one of the most popular strategies by virtual clinical trial sites, offering lucrative revenue growth opportunities for the market..

此外，“自带设备”是虚拟临床试验网站最受欢迎的策略之一，为市场提供了丰厚的收入增长机会。。

Virtual clinical trials are trending in biopharma and medical device industries to provide more convenience for patients in clinical trials. However, researchers are innovating clinical trials with a new strategy called bring-your-own-device (BYOD). This new strategy allows patients/ participants in the trial to deliver study data with their internet-enabled solutions.

虚拟临床试验正在生物制药和医疗器械行业发展，为临床试验中的患者提供更多便利。然而，研究人员正在用一种称为自带设备（BYOD）的新策略创新临床试验。这一新策略允许患者/试验参与者通过其互联网支持的解决方案提供研究数据。

Technological advancements and confidence have improved study outcomes, bringing new solutions. In recent years, clinical researchers have noticed a noticeable increase using the electronic clinical outcome assessment (eCOA) tool within trials. Most clinical trial performers are shifting toward clinical trials with the BYOD strategy.

技术进步和信心改善了研究结果，带来了新的解决方案。近年来，临床研究人员注意到在试验中使用电子临床结果评估（eCOA）工具的情况明显增加。大多数临床试验执行者正在转向BYOD策略的临床试验。

Through the BYOD strategy, patients can easily share their regular data through smartphones, laptops, tablets, and desktop computers. BYOD strategy can potentially deliver tremendous opportunities and values in the virtual clinical trials landscape. The ability of patients to use their own devices provides considerable convenience..

通过BYOD策略，患者可以通过智能手机、笔记本电脑、平板电脑和台式电脑轻松共享他们的常规数据。BYOD战略可能在虚拟临床试验领域提供巨大的机会和价值。。。

Offerings of a More Patient-centric Approach and Participation

提供更以患者为中心的方法和参与

Traditional clinical trials are complex for sponsors, providers, and participants; however, virtual clinical trials are revolutionary approaches to running clinical studies that offer more patient-centric approaches and increase patient participation. This emerging approach allows greater patient management and engagement in their care, making it simple and easier for patients from all backgrounds to participate in trials without traveling long distances or being connected to a specific institution or care facility.

传统的临床试验对于赞助商，提供者和参与者来说是复杂的；然而，虚拟临床试验是进行临床研究的革命性方法，可以提供更多以患者为中心的方法并增加患者的参与。这种新兴的方法允许更多的患者管理和参与他们的护理，使来自所有背景的患者都可以简单而容易地参加试验，而无需长途旅行或连接到特定的机构或护理机构。

Furthermore, advanced systems under virtual clinical trials support delivering more benefits to patient participants. For example, Clinical Data Management (CDM) systems help to correctly and securely collect and manage data without disturbing patient time..

此外，虚拟临床试验下的先进系统支持为患者参与者提供更多益处。例如，临床数据管理（CDM）系统有助于正确、安全地收集和管理数据，而不会干扰患者的时间。。

INDUSTRY RESTRAINTS

行业限制

Ethical Consideration and Regulatory Compliance

道德考虑和法规遵从性

Clinical trials are highly complex and stringently regularized due to the high-cost investment and involvement of a huge patient population and associated data. Vendors are ensuring compliance with diverse regulatory requirements and ethical standards. The worldwide environment of virtual clinical trials often spans multiple jurisdictions, each with its regulations.

由于高成本投资以及大量患者人群和相关数据的参与，临床试验非常复杂且严格规范。供应商正在确保遵守各种监管要求和道德标准。虚拟临床试验的全球环境通常跨越多个司法管辖区，每个司法管辖区都有其规定。

Vendors must ensure that the regulatory bodies they submit to are aware of all trial techniques and follow their guidelines. Regulatory bodies must comply with new guidelines and amend existing guidance to keep up with the emerging technologies and virtual trial approaches. Furthermore, ethical challenges, such as informed consent in virtual clinical trials, are still challenging, as perhaps the risk and depth of the trial have not been fully conveyed, and patients can still accept without full understanding..

供应商必须确保其提交的监管机构了解所有试验技术并遵循其指导原则。监管机构必须遵守新的指导方针，并修改现有的指导方针，以跟上新兴技术和虚拟试验方法的发展。此外，道德挑战，例如虚拟临床试验中的知情同意，仍然具有挑战性，因为可能尚未充分传达试验的风险和深度，患者仍然可以在不完全理解的情况下接受。。

COMPETITIVE LANDSCAPE

竞争格局

The global virtual clinical trials market report contains exclusive data on 32 vendors. The market is highly fragmented, and large corporations dominate it. However, there are significant growth opportunities for new entrants. Though the market is dominated by major players, many investigational and small companies are coming into existence with virtual clinical trial solutions..

全球虚拟临床试验市场报告包含32家供应商的独家数据。市场高度分散，大公司占据主导地位。然而，对于新进入者来说，有着巨大的增长机会。尽管市场由主要参与者主导，但许多研究性和小型公司正在通过虚拟临床试验解决方案应运而生。。

Dassault Systemes, Medable, Science 37, THREAD, Castor, Clinical Ink, IQVIA, and Icon are some leading companies accounting for more than 50% of the market share in the global virtual clinical trials market. These vendors are continuously developing and investing in virtual clinical trial tools and are expected to dominate the market with continued engagement..

达索系统、Medable、Science 37、THREAD、Castor、Clinical Ink、IQVIA和Icon是一些领先的公司，在全球虚拟临床试验市场上占据50%以上的市场份额。这些供应商正在不断开发和投资虚拟临床试验工具，并有望通过持续参与主导市场。。

Key Vendors

主要供应商

Dassault Systemes

达索系统

Medable

可治疗的

Science 37

科学37

THREAD

螺纹

Castor

脚轮

Clinical ink

临床墨水

IQVIA

IQVIA

Icon Plc

图标Plc

Other Prominent Vendors

其他知名供应商

Accenture

埃森哲

Clario

克拉里昂

Delve Health

Delve健康

Cambridge Cognition

剑桥认知

Labcorp

Labcorp

ObvioHealth

ObvioHealth

Signant Health

Signant健康

Thermo Fisher Scientific

赛默飞世尔科技

Advarra

警告

CMIC Holdings

CMIC控股公司

Curavit Clinical Research

Curavit临床研究

Jeeva Informatics Solutions

Jeeva信息解决方案

LEO Innovation (Studies & Me)

LEO创新（研究与Me）

Oracle

甲骨文

Paraxel International Corporation

Paraxel国际公司

ProPharma Group

ProPharma集团

PCM Trials

PCM试验

M&B Sciences

工商管理科学

AUTOCRUITMENT

自动修复

ClinicalConnection

ClinicalConnection

CSSi

CSSI

Tigermed

老虎

Trialize

三合一

Florence Healthcare

佛罗伦萨医疗保健

Key Attributes:

关键属性：

Report Attribute

报表属性

Details

详细信息

No. of Pages

页数

150

150

Forecast Period

预测期

2023 - 2029

2023 - 2029

Estimated Market Value (USD) in 2023

2023年估计市值（美元）

$2.64 Billion

26.4亿美元

Forecasted Market Value (USD) by 2029

2029年预测市场价值（美元）

$7.11 Billion

71.1亿美元

Compound Annual Growth Rate

年均复合增长率

17.9%

17.9%

Regions Covered

覆盖的区域

Global

全球

Key Topics Covered:

涵盖的关键主题：

Chapter 1: Virtual Clinical Trials Market Overview

第一章：虚拟临床试验市场概述

Executive Summary

执行摘要

Key Findings

主要调查结果

Chapter 2: Virtual Clinical Trials Market

第二章：虚拟临床试验市场

Global: Projected Revenue of Virtual Clinical Trials Market (2020-2029; $ Millions)

全球：虚拟临床试验市场的预计收入（2020-2029；百万美元）

Chapter 3: Virtual Clinical Trials Market Prospects & Opportunities

第三章：虚拟临床试验市场前景与机遇

Virtual Clinical Trials Market Opportunities & Trends

虚拟临床试验市场机遇与趋势

Virtual Clinical Trials Market Drivers

虚拟临床试验市场驱动因素

Virtual Clinical Trials Market Constraints

虚拟临床试验市场制约因素

Chapter 4: Virtual Clinical Trials Market Segmentation Data

第4章：虚拟临床试验市场细分数据

Global: Projected Revenue by Study Type (2020-2029; $ Millions)

全球：按学习类型划分的预计收入（2020-2029；百万美元）

Interventional Study

介入性研究

Other Study Type

其他研究类型

Global: Projected Revenue by Phases (2020-2029; $ Millions)

Late Stage

后期

Early Stage

早期阶段

Global: Projected Revenue by Company Size (2020-2029; $ Millions)

全球：按公司规模划分的预计收入（2020-2029；百万美元）

Small & Mid-Sized Companies

中小型公司

Large Sized Companies

大型公司

Global: Projected Revenue by Therapeutic Area (2020-2029; $ Millions)

全球：按治疗领域划分的预计收入（2020-2029；百万美元）

Oncology

肿瘤学

Rare & Genetic Diseases

罕见病和遗传病

Cns- Central Nervous Systems Diseases

中枢神经系统疾病

Immunology Diseases

免疫学疾病

Other Therapeutic Area

其他治疗领域

Chapter 5: Key Regions Overview

第五章重点区域概述

Chapter 6: Virtual Clinical Trials Market Industry Overview

Virtual Clinical Trials Market - Competitive Landscape

虚拟临床试验市场-竞争格局

Virtual Clinical Trials Market- Key Vendor Profiles

Virtual Clinical Trials Market- Other Prominent Vendors

虚拟临床试验市场-其他知名供应商

Virtual Clinical Trials Market - Key Strategic Recommendations

虚拟临床试验市场-关键战略建议

For more information about this report visit https://www.researchandmarkets.com/r/myacxq

有关此报告的更多信息，请访问https://www.researchandmarkets.com/r/myacxq

About ResearchAndMarkets.com

关于ResearchAndMarkets.com

ResearchAndMarkets.com is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.

ResearchAndMarkets.com是全球领先的国际市场研究报告和市场数据来源。我们为您提供有关国际和地区市场、关键行业、顶尖公司、新产品和最新趋势的最新数据。